Henry Fechner

12PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyRegenerative medicine (incl. stem cells)Molecular targetsWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 28, 2026
Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice.

Leslie Elsner, Luisa Hinze, Ahmet Hazini

|Jul 29, 2025
Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3.

Anja Geisler, Babette Dieringer, Leslie Elsner

|Mar 20, 2025
Mitigating murine acute and chronic Coxsackievirus B3-induced myocarditis with human right atrial appendage-derived stromal cells.

Muhammad El-Shafeey, Kathleen Pappritz, Isabel Voss

|Jan 08, 2025
Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells.

Leslie Elsner, Babette Dieringer, Anja Geisler

|Oct 26, 2024
Oncolytic Coxsackievirus B3 Strain PD-H Is Effective Against a Broad Spectrum of Pancreatic Cancer Cell Lines and Induces a Growth Delay in Pancreatic KPC Cell Tumors In Vivo.

Anja Geisler, Babette Dieringer, Leslie Elsner

|Jun 19, 2024
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320.

Maxim Girod, Anja Geisler, Luisa Hinze

Pageof 2

Frequent Collaborators

8 joint publications

Jens Kurreck

4 joint publications

Sophie Van Linthout

3 joint publications

Karin Klingel

2 joint publications

Jürgen Eberle